The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with urothelial cancer of the bladder: BTCRC-GU15-023 study.
 
Monika Joshi
Consulting or Advisory Role - Bayer
 
Leonard Tuanquin
No Relationships to Disclose
 
Matthew Kaag
No Relationships to Disclose
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Castle Biosciences; Eisai; Exelixis; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Newlink Genetics
 
Jason Liao
No Relationships to Disclose
 
Suzanne Merrill
No Relationships to Disclose
 
Dana Musapatika
No Relationships to Disclose
 
David DeGraff
No Relationships to Disclose
 
Hong Zheng
No Relationships to Disclose
 
Joshua Warrick
No Relationships to Disclose
 
Sheldon L. Holder
Employment - Hope Healthcare
Consulting or Advisory Role - Valeant/Dendreon
Travel, Accommodations, Expenses - Valeant/Dendreon
 
Mark Stein
No Relationships to Disclose
 
Joseph J. Drabick
Honoraria - Merck; Novartis